Bellus Health Inc (US:BLU) has 3 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These. News for Bellus Health Inc Stock (BLU) · BELLUS Health to Participate in Jefferies Virtual London Healthcare Conference · Earnings Preview: Bellus Health (BLU) Q3. Stock price history for BELLUS Health. Get the latest BELLUS Health Inc. (BLU) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. BELLUS Health NasdaqGS:BLU Stock Report ; Last Price. US$ ; Market Cap. US$b ; 7D. 0% ; 1Y. % ; Updated. 28 Jun,
At this time, the firm appears to be overvalued. BELLUS Health shows a prevailing Real Value of $ per share. The current price of the firm is $ Our. BELLUS Health Inc is listed in the sector of the Toronto Stock Exchange with ticker BLU. The last closing price for BELLUS Health was $ BELLUS Health (json-gui.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BELLUS Health | Toronto S.E.: BLU | Toronto. BELLUS Health Inc. (BLU) is an innovative biopharmaceutical development company dedicated to creating novel therapeutics for conditions with high unmet medical. BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of RCC and other hypersensitization-related. BELLUS Health Analyst Opinions ; 03/22/23, RBC Capital Markets. Maintained Buy ; 03/22/23, H.C. Wainwright & Co. Maintained Buy. Get free historical data for BLU. You'll find the closing price, open, high, low, change and %change of the BELLUS Health Inc. Stock for the selected range of. Bellus Health Inc. market cap history and chart from to BLU was delisted after stock price by the number of shares outstanding. You can watch BLU and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling. BELLUS Health Inc. (BLU): $ · Get Rating · Component Grades · Latest BLU News From Around the Web.
View BELLUS Health (BLU) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the. Based on 5 Wall Street analysts offering 12 month price targets for BELLUS Health in the last 3 months. The average price target is $ with a high forecast. Stock Range ; Today's Range. Low: ; 52 Week Range. Low: - ; Liquidity liquidity info. Low. BELLUS Health slides on pricing $M stock offering in Canada, U.S.. RTTNews d. Bellus Health Prices Public Offering Of Mln Shares At US. Bellus Health Inc. Stock Forecast. Open Broker Account. $ +0 (+0%). At Close: Sep 27, Real-time prices appear during market hours. BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need. Free BELLUS Health (BLU) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions. BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other. BLU BELLUS Health · High. · Low. · Volume. 0 · Open. · Pre Close. · Turnover. · Turnover Ratio. % · P/E (Static). Loss.
See Bellus Health funding rounds, investors, investments, exits and more. Evaluate their financials based on Bellus Health's post-money valuation and. Bellus Health Inc. - 4 Year Stock Price History | BLU · The latest closing stock price for Bellus Health Inc. on June 28, is · The all-time high. A high-level overview of BELLUS Health Inc. (BLU:CA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. Recent Bellus Health Inc news. Filter ; Tuesday, 16 May % ; morningstar. BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK. BELLUS, a Canada-based, late-stage biopharmaceutical company working to better the lives of Why BELLUS Health Stock Is Rocketing Higher Today. Motley Fool.